Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Stock Information | RedChip

Orchestra BioMed Holdings Inc. (NASDAQ: OBIO)


$8.47
-0.0600 ( -0.70% ) 105.0K

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Market Data


Open


$8.47

Previous close


$8.53

Volume


105.0K

Market cap


$304.56M

Day range


$8.17 - $8.75

52 week range


$4.22 - $11.69

SEC Fillings


Form Type Description Pages Date
def Proxies and info statements 5 Apr 30, 2024
8-k 8K-related 13 Mar 29, 2024
3 Insider transactions 2 Mar 28, 2024
4 Insider transactions 1 Mar 28, 2024
10-k Annual reports 130 Mar 27, 2024
8-k 8K-related 38 Mar 07, 2024
5 Other 1 Feb 14, 2024
8-k 8K-related 13 Nov 28, 2023
8-k 8K-related 35 Nov 14, 2023
10-q Quarterly Reports 89 Nov 13, 2023

Latest News